Key result
In Chinese patients with non-valvular atrial fibrillation undergoing coronary stenting, the incidence of MACCE was 17.8% and all-cause death was 9.6% over a median follow-up of 36.2 months.
Why the study?
The study aimed to evaluate predictors for adverse cardiovascular outcomes in patients with atrial fibrillation undergoing coronary stenting.
Cohort
Yes
Chinese patients with non-valvular atrial fibrillation undergoing coronary stenting experience high rates of mortality and MACCE, with specific clinical factors predicting ischemic and bleeding risks.
Answers are grounded in this paper and cite their sources.
Supports CHA2DS2-VASc ≥5 for risk stratification post-stenting in AF; leaves open whether score-guided interventions improve outcomes.
OBJECTIVE: This study aimed to evaluate predictors for adverse cardiovascular outcomes in patients with atrial fibrillation (AF) undergoing coronary stenting. METHODS: We retrospectively recruited consecutive patients with previously documented non-valvular AF who underwent coronary stenting between January 2010 and June 2015 in 12 hospitals of Beijing, China. Major adverse cardiac/cerebrovascular events (MACCE) were a composite of all-cause death, non-fatal myocardial infarction, repeat revascularization, and ischaemic stroke/systemic thromboembolism (IS/STE). Major bleeding referred to grade 2 or higher of Bleeding Academic Research Consortium criteria. The median follow-up duration was 36.2 months. There were 230 (9.6%) deaths, 96 (4.0%) IS/STE, 426 (17.8%) MACCE, and 72 (3.0%) major bleeding. Multivariate Cox regression yielded predictive models for (1) all-cause death: diabetes, prior myocardial infarction, chronic kidney disease (CKD), ST-segment elevation myocardial infarction (STEMI) at presentation, heart failure, no use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and statins; (2) IS/STE: advanced age, prior history of ischaemic stroke and intracranial haemorrhage; (3) MACCE: prior history of myocardial infarction and ischaemic stroke, CKD, STEMI, heart failure, and no statin use; (4) major bleeding: prior major bleeding, prior myocardial infarction, CKD and use of oral anticoagulants. CONCLUSION: Chinese patients with AF and coronary stenting had high mortality and incidence of MACCE. We compiled separate predictive models for all-cause death, IS/STE, MACCE, and major bleeding.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2021) conducted a cohort in Atrial fibrillation undergoing coronary stenting. Clinical risk factors was evaluated on Major adverse cardiac/cerebrovascular events (MACCE). In Chinese patients with non-valvular atrial fibrillation undergoing coronary stenting, the incidence of MACCE was 17.8% and all-cause death was 9.6% over a median follow-up of 36.2 months.
Synapse has enriched 10 related papers. Consider them for comparative context: